Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study are:
- To evaluate the safety and tolerability of MT-1303 in subjects with moderate to severe
active Crohn's Disease（CD）
- To evaluate the clinical efficacy of MT-1303 in subjects with moderate to severe active
CD.